Haematology

Uzm. Dr. Nurgül Özgür Yurttaş

Doctor and researcher İstinye Üniversitesi Gaziosmanpaşa Hastanesi İstanbul
Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 publications
    Source: OpenAlex / PubMed MeSHView publications

CV

Education and experience

From source

Experience

  • ExperienceGaziosmanpaşa Hastanesimedicalpark.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyHaematologymedicalpark.com.trFrom source
  • Department name at the sourceHematoloji Polikliniğimedicalpark.com.trFrom source
  • Institutionİstinye Üniversitesi Gaziosmanpaşa Hastanesimedicalpark.com.trFrom source
  • Area of workLeukemia, Myelogenous, Chronic, BCR-ABL PositiveExtracted from 4 publications · Model version —From source
  • Publications27 publicationsORCID, OpenAlexFrom source
  • ORCID0000-0002-9028-3483ORCIDFrom source
  • Last synchronised4 November 2026 20:53https://www.medicalpark.com.tr/hekimler/nurgul-ozgur-yurttasmedicalpark.com.tr

Scientific work

Publications on Leukemia, Myelogenous, Chronic, BCR-ABL Positive

27 publications
Publications by year Most: 6, in 2019
  1. 2014: 2 publications
  2. 2015: 4 publications
  3. 2016: 1 publication
  4. 2017: 3 publications
  5. 2018: 1 publication
  6. 2019: 6 publications
  7. 2020: 2 publications
  8. 2021: 3 publications
  9. 2022: 1 publication
  10. 2023: 2 publications
  11. 2024: 1 publication
  12. 2025: 0 publications
  13. 2026: 1 publication
  1. Intravesical Allogeneic Platelet Concentrate for Refractory BK Virus-Associated Haemorrhagic Cystitis After Allogeneic Haematopoietic Stem Cell Transplantation

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15197407 PMID 42881869 Open-access full textSource: ORCID

  2. Ineffectiveness of therapeutic plasma exchange as a last resort in severe COVID-19 cases: Experience from a tertiary intensive care unit

    Therapeutic Apheresis and Dialysis, 2024

    DOI 10.1111/1744-9987.14219 PMID 39425626 1 citation (Europe PMC) Source: ORCID

  3. Entecavir‐induced neutropenia in an adult living donor liver transplant recipient: Successful conversion to tenofovir alafenamide

    Clinical Case Reports, 2023

    DOI 10.1002/ccr3.7741 PMID 37575459 1 citation (Europe PMC) Open-access full textSource: ORCID

  4. Effect of Tyrosine Kinase Inhibitor Therapy on Estimated Glomerular Filtration Rate in Patients with Chronic Myeloid Leukemia

    Clinical Lymphoma Myeloma & Leukemia, 2023

    DOI 10.1016/j.clml.2023.12.004 PMID 38281820 5 citations (OpenAlex) Open-access full textSource: OpenAlex

  5. Clinical Application of Biomarkers for Hematologic Malignancies

    BENTHAM SCIENCE PUBLISHERS eBooks, 2022

    DOI 10.2174/9789815040463122010010 Source: OpenAlex

  6. Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia: Real-Life Data and a Single-Center Experience

    Clinical Lymphoma Myeloma & Leukemia, 2021

    DOI 10.1016/j.clml.2021.04.005 PMID 34052176 6 citations (Europe PMC) Source: OpenAlex

  7. Tocilizumab in COVID-19: The Cerrahpaşa-PREDICT score

    Journal of Infection and Chemotherapy, 2021

    DOI 10.1016/j.jiac.2021.05.007 PMID 34120824 8 citations (Europe PMC) Open-access full textSource: OpenAlex

  8. Candida esophagitis incidentally detected by 18F‐FDG PET/CT in a patient with CNS lymphoma

    Clinical Case Reports, 2021

    DOI 10.1002/ccr3.4322 PMID 34084527 4 citations (OpenAlex) Open-access full textSource: OpenAlex

  9. Follicular lymphoma generating in a patient with non-small cell lung cancer following nivolumab discontinuation

    Journal of Oncology Pharmacy Practice, 2020

    DOI 10.1177/1078155220918627 PMID 32299317 1 citation (Europe PMC) Source: OpenAlex

  10. Novel therapeutic approaches in chronic myeloid leukemia

    Leukemia Research, 2020

    DOI 10.1016/j.leukres.2020.106337 PMID 32200189 44 citations (OpenAlex) Source: OpenAlex

View all 27 publications